RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter

Dworkin, SI., Lambert, P., Sizemore, GM., Carroll, F., & Kuhar, MJ. (1998). RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter. Synapse, 30(1), 49-55.

Abstract

RTI-113 [3 beta-(4-chlorophenyl)tropan-2 beta carboxylic acid phenyl ester hydrochloride], one of many phenyltropanes potent at and selective for DAT, inhibited self-administration of cocaine in rat, at doses that did not alter responding maintained by food. The doses that inhibited cocaine intake produced significant levels of occupancy of DAT. Synapse 30:49-55, 1998. (C) Wiley-Liss, Inc., Inc

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.